FDAapproval95% confidence
FDA Approves First Generics of Gilotrif (afatinib) Tablets
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to AbbVie; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Infectious Disease · Antiviral
- Sub-indication
- General
Related signal: FDA Approves Supplemental Application for KALETRA by AbbVie